Moreover, SOCS2 promoted proliferation, anchorage-independent growth, apoptosis resistance, and in vivo tumor growth of prostate and colon cancer cell lines [42−44], testifying to its oncogenic potential. Here, SOCS2 is linked to neoplasm.